BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Oct 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-10-15

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-15	Common Stock	S	1000	$108.241	Disposed	26758	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	228754	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed March 2, 2015

F2: The price in column 4 is an average weighted price. The price actually received ranged from $103.27 to $109.74. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.